RET and breast cancer: The association reported here between RET SNP rs2435357 and OS in ER+ BC patients is of utmost importance and fully consistent with the observation that RET over-expression is associated with poor prognosis in ER+ BC and strongly candidate this SNP as prognostic factor in ER+ breast cancer.